NCT06467526
Efficacy and Safety of Hydroxychloroquine in the Treatment of Sudden Sensorineural Hearing Loss
At risk: Primary completion moved 7 months later.
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗
Notable Primary completion pushed from May 31, 2026 to Dec 31, 2026 Show 5 more changesShow less
- Recruitment opened
- Eligibility criteria expanded, about 17 words
- Study sites: 0 to 1
- Start date changed from estimate of Jul 1, 2024 to Sep 10, 2024
- Study description expanded, about 7 words
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Hearing improvement
Timeframe: from screening until 3 months
Secondary (2)
Word recognition score
Tinnitus severity
Arms and interventions
Hydroxychloroquine groupExperimental
Hydroxychloroquine with steroid
Control groupOther
Steroid only
Drugs: Hydroxychloroquine, Steroid
Sites
1 site in 1 country
- Kaohsiung Chang Gung Memorial HospitalKaohsiung City, Taiwan